Abstract
We investigated the antimicrobial resistance in gonococci 2009 to 2014 in Yaoundé, Cameroon, and recommend revisions of the Cameroonian treatment guideline. We observed a high resistance to ciprofloxacin (17.6%) but no ceftriaxone resistance. Ceftriaxone should replace ciprofloxacin as the recommended first-line treatment for urethral/vaginal discharge. Enhanced resistance surveillance in Africa is essential.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anti-Bacterial Agents / pharmacology*
-
Azithromycin / pharmacology
-
Cameroon
-
Ciprofloxacin / pharmacology
-
Drug Resistance, Multiple, Bacterial*
-
Female
-
Gonorrhea / microbiology
-
Humans
-
Male
-
Microbial Sensitivity Tests
-
Neisseria gonorrhoeae / drug effects*
-
Neisseria gonorrhoeae / isolation & purification
-
Practice Guidelines as Topic
-
Sentinel Surveillance
-
Vagina / microbiology
Substances
-
Anti-Bacterial Agents
-
Ciprofloxacin
-
Azithromycin